MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2019 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 this is to inform you that the meeting of the Board of Directors of the Company will be held on Monday 12th August 2019 at New Delhi.
1. To consider and approve the standalone unaudited financial results for the quarter ended on 30th June 2019 along with Limited Review Reports.
2. Any other item if any with the permission of the Chair
Further to our communication dated 29th June 2019 and pursuant to the Companys code of conduct to regulate monitor and report trading by designated persons and the SEBI (Prohibition of Insider Trading) Rules 2015 the trading window shall remain closed upto 48 hours after the declaration of financial results of the Company for the quarter ended 30th June 2019.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
